Clinical Trial Update: Safety and Efficacy Study of Trabectedin for the Treatment of Localized Myxoid / Round Cell Liposarcoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating trabectedin for localized myxoid liposarcoma reports safety and efficacy findings; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myxoid Liposarcoma

Drugs mentioned

• Trabectedin (trabectedin)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Liposarcoma,Myxoid | Phase 2 | Status: COMPLETED | Results posted: 2014-03-11